| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CHEMED CORP | CEO - Vitas Healthcare | Stock Option (right to buy with tandem tax withholding) | 32,819 | $14,564,744 | $443.79 | 21 Oct 2025 | Direct |
| CHEMED CORP | CEO - Vitas Healthcare | Capital Stock | 852 | $400,065 | $469.56 | 13 Feb 2026 | Direct |
| CHEMED CORP | CEO - Vitas Healthcare | Performance Stock Units | 2,212 | 13 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CHE | CHEMED CORP | 13 Feb 2026 | 6 | +$90,625 | 4 | CEO - Vitas Healthcare | 17 Feb 2026, 15:58 |
| CHE | CHEMED CORP | 21 Oct 2025 | 1 | +$7,755,674 | 4 | CEO - Vitas Healthcare | 22 Oct 2025, 17:27 |
| CHE | CHEMED CORP | 27 Aug 2025 | 0 | $0 | 3 | CEO - Vitas Healthcare | 27 Aug 2025, 13:16 |